Q3 2022 Holdings
Filed 2022-11-14 | 39 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $446.8M | 1,265,555 | 31.0% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $301.4M | 3,555,555 | 20.9% |
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $294.3M | 2,850,000 | 20.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | Common | 02043Q107 | $221.2M | 1,105,000 | 15.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | Common | 09058V103 | $114.0M | 9,050,000 | 7.9% |
| Aadi Biosciences Inc(WHWK) | Common | 00032Q104 | $40.3M | 2,849,402 | 2.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | Common | 03237H101 | $18.3M | 650,000 | 1.3% |
| Apellis Pharmaceuticals Inc(APLS) | Common | 03753U106 | $691.5K | 10,125,000 | 0.0% |
| United Therapeutics Corp(UTHR) | Common | 91307C102 | $612.8K | 2,926,500 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $387.7K | 5,550,555 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | Common | 803607100 | $351.0K | 3,175,000 | 0.0% |
| Horizon Therapeutics PLC | Common | G46188101 | $317.2K | 5,125,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $279.8K | 26,800,000 | 0.0% |
| Seagen Inc(SGENUSD) | Common | 81181C104 | $255.2K | 1,865,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $176.9K | 4,900,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | Common | 46583P102 | $105.8K | 5,900,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $99.8K | 1,535,000 | 0.0% |
| Krystal Biotech Inc(KRYS) | Common | 501147102 | $88.9K | 1,275,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $86.4K | 9,020,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | Common | 87164F105 | $53.4K | 2,222,222 | 0.0% |
| Mersana Therapeutics Inc | Common | 59045L106 | $51.0K | 7,550,000 | 0.0% |
| Kura Oncology Inc(KURA) | Common | 50127T109 | $48.2K | 3,525,000 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | Common | 501575104 | $47.2K | 2,169,230 | 0.0% |
| Design Therapeutics Inc(DSGN) | Common | 25056L103 | $37.2K | 2,222,222 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | Common | 69353Y103 | $36.4K | 3,060,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $36.1K | 10,300,000 | 0.0% |
| Ultragenyx Pharmaceutical Inc(RARE) | Common | 90400D108 | $31.1K | 750,000 | 0.0% |
| Mannkind Corp(MNKD) | Common | 56400P706 | $28.1K | 9,100,000 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | Common | 61225M102 | $27.5K | 3,363,333 | 0.0% |
| Avidity Biosciences Inc(RNA) | Common | 05370A108 | $23.7K | 1,450,000 | 0.0% |
| Dice Therapeutics Inc | Common | 23345J104 | $21.8K | 1,075,000 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | Common | 56854Q200 | $20.9K | 3,150,000 | 0.0% |
| Nuvalent Inc(NUVL) | Common | 670703107 | $20.4K | 1,049,471 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $9.7K | 1,200,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | Common | 75943R102 | $8.9K | 400,000 | 0.0% |
| Amarin Corp PLC | Sponsored ADR | 023111206 | $6.5K | 6,000,000 | 0.0% |
| Tango Therapeutics Inc(TNGX) | Common | 87583X109 | $5.6K | 1,550,000 | 0.0% |
| IO Biotech Inc(IOBT) | Common | 449778109 | $5.6K | 2,055,883 | 0.0% |
| Bioatla Inc(BCAB) | Common | 09077B104 | $4.4K | 575,000 | 0.0% |